Literature DB >> 21883149

A β-amyloid oligomer directly modulates P/Q-type calcium currents in Xenopus oocytes.

M Mezler1, S Barghorn, H Schoemaker, G Gross, V Nimmrich.   

Abstract

BACKGROUND AND
PURPOSE: β-amyloid (Aβ) oligomers have been implicated in the early pathophysiology of Alzheimer's disease (AD). While the precise nature of the molecular target has not been fully revealed, a number of studies have indicated that Aβ oligomers modulate neuron-specific ion channels. We recently provided evidence that Aβ oligomers suppress isolated P/Q-type calcium currents in cultured nerve cells. Using a heterologous expression system, we aimed to prove a direct effect on the membrane channel mediating such current. EXPERIMENTAL APPROACH: The effects of a synthetically generated Aβ oligomer, Aβ globulomer, were investigated on P/Q-type currents recorded from Xenopus laevis oocytes expressing the full P/Q-type calcium channel or the pore-forming subunit only. We also examined the effects of Aβ globulomer on recombinant NMDA receptor currents. Finally, we compared the modulation by Aβ globulomer with that induced by a synthetic monomeric Aβ. KEY
RESULTS: Aβ globulomer directly and dose-dependently modulated P/Q-type calcium channels. A leftward shift of the current-voltage curve indicated that the threshold for channel opening was reduced. The effect of Aβ globulomer was also present when only the α1A subunit of the normally tripartite channel was expressed. In contrast, the monomeric Aβ had no effect on P/Q current. Also globulomer Aβ had no effect on glutamate-induced NMDA currents. CONCLUSIONS AND IMPLICATIONS: The α1A subunit of the P/Q-type calcium channel is directly modulated by oligomeric Aβ. Threshold reduction as well as an increase in current at synaptic terminals may facilitate vesicle release and could trigger excitotoxic events in the brains of patients with AD.
© 2011 Abbott GmbH & Co. KG. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21883149      PMCID: PMC3372738          DOI: 10.1111/j.1476-5381.2011.01646.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Authors:  Dominic M Walsh; Igor Klyubin; Julia V Fadeeva; William K Cullen; Roger Anwyl; Michael S Wolfe; Michael J Rowan; Dennis J Selkoe
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

2.  The binding of kappa-Conotoxin PVIIA and fast C-type inactivation of Shaker K+ channels are mutually exclusive.

Authors:  E Dietlind Koch; Baldomero M Olivera; Heinrich Terlau; Franco Conti
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

3.  Novel Cav2.1 splice variants isolated from Purkinje cells do not generate P-type Ca2+ current.

Authors:  Taiji Tsunemi; Hironao Saegusa; Kinya Ishikawa; Shin Nagayama; Takayuki Murakoshi; Hidehiro Mizusawa; Tsutomu Tanabe
Journal:  J Biol Chem       Date:  2001-12-27       Impact factor: 5.157

4.  Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones.

Authors:  K G Sutton; D J Martin; R D Pinnock; K Lee; R H Scott
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis.

Authors:  T Harkany; I Abrahám; W Timmerman; G Laskay; B Tóth; M Sasvári; C Kónya; J B Sebens; J Korf; C Nyakas; M Zarándi; K Soós; B Penke; P G Luiten
Journal:  Eur J Neurosci       Date:  2000-08       Impact factor: 3.386

6.  Systematic identification of splice variants in human P/Q-type channel alpha1(2.1) subunits: implications for current density and Ca2+-dependent inactivation.

Authors:  Tuck Wah Soong; Carla D DeMaria; Rebecca S Alvania; Larry S Zweifel; Mui Cheng Liang; Scott Mittman; William S Agnew; David T Yue
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

Review 7.  Deciphering the molecular basis of memory failure in Alzheimer's disease.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

8.  Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5.

Authors:  Qinwen Wang; Dominic M Walsh; Michael J Rowan; Dennis J Selkoe; Roger Anwyl
Journal:  J Neurosci       Date:  2004-03-31       Impact factor: 6.167

9.  Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo.

Authors:  Zsolt Molnár; Katalin Soós; Imre Lengyel; Botond Penke; Viktor Szegedi; Dénes Budai
Journal:  Neuroreport       Date:  2004-07-19       Impact factor: 1.837

10.  Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.

Authors:  Daniela Puzzo; Lucia Privitera; Elena Leznik; Mauro Fà; Agnieszka Staniszewski; Agostino Palmeri; Ottavio Arancio
Journal:  J Neurosci       Date:  2008-12-31       Impact factor: 6.167

View more
  17 in total

Review 1.  P/Q-type calcium channel modulators.

Authors:  V Nimmrich; G Gross
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 2.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Out-of-Register Parallel β-Sheets and Antiparallel β-Sheets Coexist in 150-kDa Oligomers Formed by Amyloid-β(1-42).

Authors:  Yuan Gao; Cong Guo; Jens O Watzlawik; Peter S Randolph; Elizabeth J Lee; Danting Huang; Scott M Stagg; Huan-Xiang Zhou; Terrone L Rosenberry; Anant K Paravastu
Journal:  J Mol Biol       Date:  2020-05-26       Impact factor: 5.469

4.  Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology.

Authors:  An T Dao; Munder A Zagaar; Amber T Levine; Samina Salim; Jason L Eriksen; Karim A Alkadhi
Journal:  Curr Alzheimer Res       Date:  2013-06       Impact factor: 3.498

Review 5.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

Review 6.  Neuronal Network Oscillations in Neurodegenerative Diseases.

Authors:  Volker Nimmrich; Andreas Draguhn; Nikolai Axmacher
Journal:  Neuromolecular Med       Date:  2015-04-29       Impact factor: 3.843

7.  Hippocampal Degeneration and Behavioral Impairment During Alzheimer-Like Pathogenesis Involves Glutamate Excitotoxicity.

Authors:  Olayemi Joseph Olajide; Ismail Tayo Gbadamosi; Emmanuel Olusola Yawson; Tolulope Arogundade; Folashade Susan Lewu; Kehinde Yomi Ogunrinola; Oluwaseun Olaniyi Adigun; Olawande Bamisi; Ezra Lambe; Leviticus Ogbenevurinrin Arietarhire; Olushola Oladapo Oluyomi; Olumayowa Kolawole Idowu; Rukayat Kareem; Nnaemeka Tobechukwu Asogwa; Philip Adeyemi Adeniyi
Journal:  J Mol Neurosci       Date:  2021-01-08       Impact factor: 3.444

Review 8.  Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.

Authors:  P Hemachandra Reddy; Ulziibat P Shirendeb
Journal:  Biochim Biophys Acta       Date:  2011-11-04

9.  Functional and structural effects of amyloid-β aggregate on Xenopus laevis oocytes.

Authors:  Jorge Parodi; Lenin Ochoa-de la Paz; Ricardo Miledi; Ataúlfo Martínez-Torres
Journal:  Mol Cells       Date:  2012-10-18       Impact factor: 5.034

Review 10.  Calcium channel blockers and dementia.

Authors:  V Nimmrich; A Eckert
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.